Not applicableActive Not RecruitingNCT05883631
What this trial is testing
RESOLVE-AF: Clinical Evaluation of the Ablacath™ Mapping Catheter and Ablamap® System Utilizing Electrographic Flow (EGF) Mapping to Resolve Extra-PV Sources of Atrial Fibrillation and Guide Ablation Therapy.
Who this might be right for
Atrial FibrillationAtrial Fibrillation, PersistentAtrial Fibrillation Paroxysmal+6 more
Cortex 400